Bank Of Montreal Theratechnologies Inc. Transaction History

Bank Of Montreal

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$0.78 - $1.01 $546 - $707	-700 Reduced 0.93%	74,627 $62,000
Q1 2023 Jun 13, 2024	BUY	$0.72 - $1.12 $53,731 - $83,582	74,627 New	74,627 $60,000
Q4 2022 Feb 01, 2023	SELL	$0.83 - $8.04 $13,719 - $132,901	-16,530 Reduced 18.0%	75,327 $66,000
Q3 2022 Nov 10, 2022	BUY	$1.98 - $2.42 $28,314 - $34,606	14,300 Added 18.44%	91,857 $219,000
Q2 2022 Aug 11, 2022	BUY	$2.21 - $2.7 $7,514 - $9,180	3,400 Added 4.58%	77,557 $185,000
Q4 2021 Feb 11, 2022	SELL	$2.92 - $3.76 $7,886 - $10,155	-2,701 Reduced 3.51%	74,157 $236,000
Q3 2021 Nov 12, 2021	SELL	$3.28 - $4.07 $32,839 - $40,748	-10,012 Reduced 11.53%	76,858 $299,000
Q2 2021 Aug 12, 2021	BUY	$3.43 - $3.96 $297,964 - $344,005	86,870 New	86,870 $336,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $115M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.